Magnetic resonance approaches and recent advances in myocardial perfusion imaging

被引：5

作者：

Lee D.C. ^{[1
]}

Klocke F.J. ^{[1
]}

机构：

[1] Feinberg Cardiovascular Research Institute, Division of Cardiology, Northwestern University, Chicago, IL 60611

来源：

Current Cardiology Reports | 2006年 / 8卷 / 1期

关键词：

Myocardial Perfusion; Cardiovascular Magnetic Resonance; Cardiac Magnetic Resonance; Magn Reson Image; Delay Enhancement Image;

D O I：

10.1007/s11886-006-0012-3

中图分类号：

学科分类号：

摘要：

Myocardial perfusion imaging identifies the presence of coronary artery stenoses and defines the functional significance of those lesions. Single photon emission computed tomography and positron emission tomography have established roles. Cardiac magnetic resonance is evolving as a promising new modality in the evaluation of myocardial perfusion. This article summarizes the current capability and recent advancements in magnetic resonance perfusion imaging. Copyright © 2006 by Current Science Inc.

引用

页码：59 / 64

页数：5

共 39 条

[1]

Pohost G.M., Hung L., Doyle M., Clinical use of cardiovascular magnetic resonance, Circulation, 108, pp. 647-653, (2003)

[2]

Grothues F., Smith G.C., Moon J.C., Et al., Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy, Am J Cardiol, 90, pp. 29-34, (2002)

[3]

Wu E., Judd R.M., Vargas J.D., Et al., Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction, Lancet, 357, pp. 21-28, (2001)

[4]

Kim R.J., Wu E., Rafael A., Et al., The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, N Engl J Med, 343, pp. 1445-1453, (2000)

[5]

Klocke F.J., Baird M.G., Lorell B.H., Et al., ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging), J Am Coll Cardiol, 42, pp. 1318-1333, (2003)

[6]

van Rugge F.P., Boreel J.J., van der Wall E.E., Et al., Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging, J Comput Assist Tomogr, 15, pp. 959-965, (1991)

[7]

Manning W.J., Atkinson D.J., Grossman W., Et al., First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease, J Am Coll Cardiol, 18, pp. 959-965, (1991)

[8]

Glenny R.W., Bernard S., Brinkley M., Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion, J Appl Physiol, 74, pp. 2585-2597, (1993)

[9]

Wilke N., Simm C., Zhang J., Et al., Contrast-enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia, Magn Reson Med, 29, pp. 485-497, (1993)

[10]

Klocke F.J., Simonetti O.P., Judd R.M., Et al., Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging, Circulation, 104, pp. 2412-2416, (2001)

← 1 2 3 4 →